Abstract: Compounds of the formula (I) in which R1, R2, X and Y have the meanings indicated in claim 1, are inhibitors of TBK1 and IKK? and can be employed, inter alia, for the treatment of cancer and inflammatory diseases.

Abstract: The treatment of diabetes and associated pathologies is achieved by administering the pyrazinone compounds of formula (I)

Abstract: The present invention relates to polymers containing at least one carbazole structural unit of the general formula (I) where Ar1, Ar2, Ar3 is each, independently of one another, denote an aryl or heteroarylgroup, which may be substituted by one or more radicals R of any desired type; m, o is, independently of one another, 0 or 1; n is 1, 2 or 3 and the dashed lines represent the linking in the polymer; and at least one arylamine structural unit of the general formula (II) and/or (III) where Ar4, Ar5, Ar7, Ar8 is each, independently of one another, an aryl or heteroaryl group, which may be substituted by one or more radicals R of any desired type; Ar6 is an aryl or heteroaryl group, which may be substituted by one or more radicals R of any desired type, or represents a group of the formula Ar9-Ar9, where Ar9 is in each case, independently, an aryl or heteroaryl group, which may be substituted by one or more radicals R of any desired type or linked to one another; p is 1, 2 or 3; q is 0 or 1 and the dashed line

Abstract: The invention generally relates to formulations for use in organic semiconductor layers of organic electronic devices, and more specifically in organic field effect transistors, to organic semiconductor layers prepared from such formulations, and to organic electronic devices and organic field effect transistors encompassing such organic semiconductor layers.

Abstract: Compounds of the formula I, in which X1, X2, X3, X4, X5, R1, R2, R3, R4, R5 and R6 have the meanings indicated in Claim 1, are kinase inhibitors and can be employed, inter alia, for the treatment of tumours.

Abstract: Compounds of the formula I in which R, R1 and R2 have the meanings indicated in Claim 1, are inhibitors of Syk, and can be employed, inter alia, for the treatment of cancer, rheumatoid arthritis and/or systemic lupus

Abstract: The present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, and to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, especially in LC displays of the PS (polymer stabilised) and PSA (polymer sustained alignment) type.

Abstract: The present invention relates to a composition, containing at least one emitter compound and at least one polymer with conjugation-interrupting units, to the use of said composition in an optoelectronic apparatus and to an optoelectronic apparatus which contains said inventive composition.

Abstract: The present invention relates to metal complexes of the formula (1) and to electronic devices, in particular organic electro-luminescent devices, comprising these metal complexes.

Abstract: Compounds of the formula I in which R1, X, Y and n have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.

Abstract: The invention relates to bimesogenic compounds of formula I wherein R11, R12, MG11, MG12, X11, X12 and Sp1 have the meaning given in claim 1, to the use of bimesogenic compounds of formula I in liquid crystal media and particular to flexoelectric liquid crystal devices comprising a liquid crystal medium according to the present invention.

Abstract: The present invention relates to novel surfactant mixtures, to the use thereof as additives, for example in preparations for surface coating, such as paints, lacquers, protective coatings and special coatings electronic or in optical applications.

Abstract: The invention relates to a means and a method for the photometric determination of the chemical oxygen demand of chloride-containing samples.

Abstract: The present invention relates to polymerizable compounds, to processes and intermediates for the preparation thereof, and to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, especially in LC displays of the PS or PSA type (“polymer sustained” or “polymer sustained alignment” respectively).

Abstract: The present invention relates to liquid-crystal (LC) media for use in LC displays of the PS (polymer stabilized) or PSA (polymer sustained alignment) type.

Abstract: The invention relates to a casting composition based on a transparent epoxy or silicone resin (1), in particular for uses in an electroluminescent component (3), which preferably emits white light. The casting composition serves as diffusion barrier for moisture or water molecules through the use of glass and/or silica particles (2).

Abstract: [Object] To provide a photosensitive siloxane resin composition excellent in alkali-solubility and in sensitivity, and also to provide a pattern-formation method employing that. [Means] The present invention provides a photosensitive siloxane resin composition comprising: a siloxane resin having silanol groups or alkoxysilyl groups, a crown ether, a photosensitive material, and an organic solvent. This photosensitive composition is cast on a substrate, subjected to imagewise exposure, treated with an alkali aqueous solution, and cured to form a pattern.

Abstract: An electronic device comprising a quantum dot and an organic host, a mixture comprising a quantum dot and an organic host, a quantum dot, a method for preparing a quantum dot (QD), and a formulation including the mixture or the quantum dot are provided.

Abstract: The present invention relates to white emitting organic electroluminescent devices having at least one blue fluorescent emitter layer.

Abstract: The invention relates to compounds of the formula (1), to a method for producing compounds of the formula (1), to the use of the compounds in electronic devices and to electronic devices containing compounds according to formula (1), preferably as electron transport materials, as matrix materials, as electron blocking materials or as emitting materials.